Silva Pharmaceuticals Limited announcements
119 Dhaka Stock Exchange announcements for Silva Pharmaceuticals Limited (SILVAPHL) since 2018: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2023 (24).
- Credit Rating Agency of Bangladesh Limited (CRAB) has announced the surveillance entity rating of the Company as \"A3\"
Credit Rating Agency of Bangladesh Limited (CRAB) has announced the surveillance entity rating of the Company as \"A3\" and \"ST-1\" in the short term (secured) along with Stable outlook based on audited financial statements (FYE 30.06.2023, 30.06.2022, 30.06.2021, 30.06.2020), bank liability position as on 30.11.2023, and other information up to the date of rating declaration.
- The Company has informed that Mrs. Sajeda Mirza who was a sponsor of the company passed away on August 20, 2023. Her tot
The Company has informed that Mrs. Sajeda Mirza who was a sponsor of the company passed away on August 20, 2023. Her total holding of 5,197,500 shares of the company will be transmitted to the account of her nominee Mr. A. R. Hassan Mirza, Son of the deceased and Sponsor of the company.
- Trading of the shares of the company will resume on 04.12.2023.
Trading of the shares of the company will resume on 04.12.2023.
- Trading of the shares of the company will remain suspended on record date i.e., 03.12.2023.
Trading of the shares of the company will remain suspended on record date i.e., 03.12.2023.
- Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled
Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle with cum benefit from 29.11.2023 to 30.11.2023 and trading of the shares will remain suspended on record date i.e., 03.12.2023.
- The auditor of the company has given the \"Emphasis of Matter\" paragraph in the Auditor\'s Report of the company for th
The auditor of the company has given the \"Emphasis of Matter\" paragraph in the Auditor\'s Report of the company for the year ended June 30, 2023. To view the details, please visit: https://www.dsebd.org/assets/pdf/16.SILVAPHL.pdf
- The company has informed it has been decided in Board of Directors\' meeting held on November 13, 2023 that the utilizat
The company has informed it has been decided in Board of Directors\' meeting held on November 13, 2023 that the utilization time of IPO proceeds has been extended up to December 31, 2024 subject to approval by the shareholders in its 22nd AGM which will be held on December 28, 2023. (cont.)
- Regarding time extension of IPO proceeds utilization
(Continuation news of SILVAPHL): The company could not complete the whole establishments of constructed new factory building and import related Capital machinery from abroad in the scheduled time. For this reason, the management could not complete the utilization of IPO fund fully. (end)
The first part of this announcement is missing from the archive. - (Q1 Un-audited): EPS was Tk. (0.06) for July-September 2023 as against Tk. 0.19 for July-September 2022; NOCFPS was Tk.
(Q1 Un-audited): EPS was Tk. (0.06) for July-September 2023 as against Tk. 0.19 for July-September 2022; NOCFPS was Tk. 0.08 for July-September 2023 as against Tk. 0.28 for July-September 2022. NAV per share was Tk. 17.04 as on September 30, 2023 and Tk. 17.10 as on June 30, 2023. Reasons for deviation in EPS, NAVPS and NOCFPS: (cont.)
- Q1 Financials
(Cont. news of SILVAPHL): EPS has decreased due to decrease in sales revenue and also increase in production cost for increase in all input raw material prices, significant volatile of the foreign currency market and limitation for opening LC to import raw materials NAVPS has decreased due to net loss incurred in this period and NOCFPS has decreased due to decrease in collection from receivables as well as sales. (end)
The first part of this announcement is missing from the archive. - Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 13, 2023 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended September 30, 2023.
- The Board of Directors has recommended 1\% Cash Dividend for all shareholders for the year ended June 30, 2023. The tota
The Board of Directors has recommended 1\% Cash Dividend for all shareholders for the year ended June 30, 2023. The total amount of cash dividend payable to the shareholders is Tk. 13,650,000.00 only for 136,500,000 shares. Date of AGM: 28.12.2023, Time: 11:30 AM, Venue: Digital Platform. Record Date: 3.12.2023. (cont.1)
- (Continuation news of SILVAPHL): The Company has reported EPS of Tk. 0.24, NAV per share of Tk. 17.10 and NOCFPS of Tk.
(Continuation news of SILVAPHL): The Company has reported EPS of Tk. 0.24, NAV per share of Tk. 17.10 and NOCFPS of Tk. 0.51 for the year ended June 30, 2023 as against Tk. 0.75, Tk. 17.03 and Tk. 1.18 respectively for the year ended June 30, 2022. Reasons for deviation in EPS and NOCFPS: EPS has decreased for lessening the sales revenue due to downtrend in local demand of product because of slowdown in the global and national economies, (cont.2)
The first part of this announcement is missing from the archive. - Price Limit Open
There will be no price limit on the trading of the shares of the Company today (29.10.2023) following its corporate declaration. However, the floor price shall be applicable accordingly.
- Dividend Declaration
(Continuation news of SILVAPHL): and also increase in cost of goods sold due to significant increase in raw material cost, power and fuel cost and also disruption in international supply chain because of crisis of US Dollar and also Russia and Ukraine War. NOCFPS has decreased due to increase in payment to employees and decrease of the collection of sales proceeds since decline in sales revenue. (end)
The first part of this announcement is missing from the archive. - Reschedule of Board Meeting under LR 19(1)
The Company has further informed that, due to unavoidable circumstances, the Board meeting under LR 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, will be held on October 28, 2023 at 3:30 PM instead of October 29, 2023 at 3:00 PM to consider, among others, audited financial statements of the Company for the year ended June 30, 2023.
- Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 29, 2023 at 3:00 PM to consider, among others, audited financial statements of the Company for the year ended June 30, 2023.
- (Q3 Un-audited): EPS was Tk. 0.06 for January-March 2023 as against Tk. 0.22 for January-March 2022; EPS was Tk. 0.39 fo
(Q3 Un-audited): EPS was Tk. 0.06 for January-March 2023 as against Tk. 0.22 for January-March 2022; EPS was Tk. 0.39 for July 2022-March 2023 as against Tk. 0.73 for July 2021-March 2022. NOCFPS was Tk. 0.88 for July 2022-March 2023 as against Tk. 1.13 for July 2021-March 2022. NAV per share was Tk. 17.25 as on March 31, 2023 and Tk. 17.03 as on June 30, 2022. (cont.)
- Q3 Financials
(Continuation news of SILVAPHL): The company has further informed that EPS has been decreased due to increase in COGS, raw material price and devaluation of local currency. NOCFPS has been decreased due to increase in payment for cost and expenses. (end)
The first part of this announcement is missing from the archive. - Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 30, 2023 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended March 31, 2023.
- Dividend Disbursement
The Company has informed that it has disbursed the cash dividend for the year ended June 30, 2022 to the respective shareholders.
- Q2 Financials
(Q2 Un-audited): EPS was Tk. 0.14 for October-December 2022 as against Tk. 0.22 for October-December 2021; EPS was Tk. 0.33 for July-December 2022 as against Tk. 0.50 for July-December 2021. NOCFPS was Tk. 0.55 for July-December 2022 as against Tk. 0.82 for July-December 2021. NAV per share was Tk. 17.19 as on December 31, 2022 and Tk. 17.03 as on June 30, 2022.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 30, 2023 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended December 31, 2022.
- Credit Rating Agency of Bangladesh Limited (CRAB) has assigned entity rating of the Company as \"A3\" and \"ST-1 (secure
Credit Rating Agency of Bangladesh Limited (CRAB) has assigned entity rating of the Company as \"A3\" and \"ST-1 (secured by FDR) \", \"ST-3\" in the short term along with Stable outlook based on audited financial statements as on June 30, 2022, bank liability position as on November 30, 2022 and other relevant quantitative as well as qualitative information up to the date of rating declaration.
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.